IRadimed CorporationIRMDNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+17.5%
5Y CAGR+19.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+17.5%/yr
vs +13.6%/yr prior
5Y CAGR
+19.1%/yr
Consistent
Acceleration
+3.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$19.49M+15.4%
2024$16.89M+9.7%
2023$15.40M+28.1%
2022$12.02M+23.1%
2021$9.76M+19.9%
2020$8.14M-7.6%
2019$8.82M+22.2%
2018$7.21M+29.5%
2017$5.57M-9.5%
2016$6.15M-